XYL Stock Price Today (October 2026) — Xylem Inc. Analysis & Key Metrics 2026-10-07
Xylem Inc. (XYL) is trading at $101.82, down 2.63% today (as of October 2026). The stock continues to show pressure below major moving averages, attracting attention from investors looking for Industrials growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $153.88 (51.1% upside).
- Volatility is moderate (25.02% annualized), implying notable price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: steady revenue (1.50% YoY) alongside competitive pressures in the Specialty Industrial Machinery space.
XYL Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Xylem Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $25.55B
P/E Ratio
Forward P/E: 17.63
Revenue Growth
Year over Year
Analyst Target
+51.1% upside potential
Key Investor Questions About XYL
What investors need to know before buying
Based on current market data, XYL presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 38.65)
- Fundamentals say: Mixed signals (nuanced financial profile)
XYL's growth trajectory depends on its ability to expand within the Specialty Industrial Machinery sector while managing margin pressures.
- Future growth will depend on performance in core Specialty Industrial Machinery operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for XYL investors include debt exposure and competitive dynamics in the Specialty Industrial Machinery industry.
- $3.06B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Specialty Industrial Machinery.
52-Week Trading Range
Over the past year, XYL stock traded between $98.58 and $154.27 and currently trades near the low end of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 25.02% annualized volatility and β=0.85, the stock exhibits moderate correlation to market moves—making XYL suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Xylem (XYL) Stock Could Be 35% Undervalued As Cash Flow Holds Up
Xylem shares have slipped over the past year, which puts a spotlight on a simple question for investors who care about fundamentals. Is the current price still in line with the cash flows the business is expected to generate over time, or has sentiment moved ahead of or behind that stream of money? The stock has fallen 27.2% over the past year, which raises the stakes on whether the recent slide now better reflects the value of its future cash flows. The company’s focus on water...
Xylem (XYL) Raises $1.5b As Undervalued Narrative Faces A Market Test
Xylem (XYL) has just raised roughly US$1.5b through a trio of fixed rate, callable senior notes, giving the water technology group fresh capital that stock investors will watch closely. Recent trading tells a different story to the fresh capital raise. Xylem's share price has fallen about 9.5% over the past month and is down roughly 25% year to date, while the 3 year total shareholder return is still positive at about 17%. This suggests that long term holders have seen gains even as shorter...
Custom Truck One Source, Terex, Xylem, Onterris, and Oshkosh Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the 10-year Treasury yield jumped to 5.14%, reaching levels last seen in 2007 and raising borrowing costs across the economy. U.S. stocks fell early Thursday, according to the Associated Press, as surging Treasury yields and rebounding energy prices weighed on financial markets.
Xylem Stock: Is XYL Underperforming the Industrial Sector?
Xylem has underperformed the Industrial sector over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Xylem (XYL) Down 7.1% Since Last Earnings Report: Can It Rebound?
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GE HealthCare Technologies (GEHC) Names A New CFO As Its Undervalued Narrative Faces A Test
GE HealthCare Technologies (GEHC) has drawn fresh attention after announcing William K. Grogan as its incoming Chief Financial Officer, effective September 14, 2026, following his finance leadership roles at Xylem and IDEX. For investors watching GE HealthCare Technologies, the recent CFO news comes after a strong 30 day share price return of 22% and a 90 day share price return of 15.7%. However, the year to date share price return is down 10.76%, and the 1 year total shareholder return is...
Xylem (XYL) Could Be 23% Below Fair Value Following Its Q2 Profit Outlook Lift
Xylem (XYL) is back in focus after its Q2 FY2026 results showed stronger profitability. The company raised adjusted EPS guidance and improved its adjusted EBITDA margin outlook, despite trimming its full year revenue forecast. See our latest analysis for Xylem. Xylem's latest earnings update has arrived after a mixed share price run, with the stock at US$116.21 and a year to date share price return down 15.24%, while the 3 year total shareholder return of 19.86% contrasts with a 1 year total...
What Should Xylem (XYL) Investors Make Of Its New CFO And Board Pick?
Xylem (NYSE:XYL) appointed Andrea van der Berg as Chief Financial Officer and Executive Vice President. The company also added D. Christian Koch to its Board of Directors. These leadership changes highlight a refreshed focus on financial oversight and board-level experience. Leadership moves at Xylem keep attention on companies that prioritize resilient balance sheets and steadier earnings profiles, which makes it worth looking at a broader group of lower-risk stocks through 79 resilient...
GE HealthCare names new CFO
William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.
Xylem Stock: Analyst Estimates & Ratings
Xylem has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.
Explore More Analysis for XYL
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 27, 2026 (before the open)
Frequently Asked Questions
Common investor questions about Xylem Inc.
Xylem Inc. (XYL) is currently trading at $101.82. The RSI (14-day) is at 38.6, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $153.88 implies 51.1% upside from current levels. Volatility is moderate at 25.0% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Xylem Inc. (XYL): The trailing P/E ratio is 25.77, which is in line with broader market averages. The forward P/E is 17.63, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.53, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 2.27. Price-to-Sales is 2.74. Valuation should be compared to Specialty Industrial Machinery industry peers for context, as different sectors trade at different multiples.
Based on 16 analysts covering XYL, the consensus price target is $153.88. This represents a 51.1% upside from the current price of $101.82. The range spans from a low target of $129.00 to a high target of $180.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Xylem Inc. (XYL) pays a dividend with a current yield of approximately 1.69%. The annualized dividend rate is $1.66 per share. The payout ratio is 39.5%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was Aug 27, 2026.
Key risks for Xylem Inc. (XYL) investors include: 1. Moderate volatility (25.0% annualized)—price swings are notable. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Specialty Industrial Machinery sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Xylem Inc.'s (XYL) current debt and financial health profile: Total debt stands at $3.06B. The debt-to-equity ratio is 0.29x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 1.61, indicating strong short-term liquidity. The quick ratio is 1.16. The company holds $1.28B in cash and equivalents. Free cash flow is positive at $1.18B, providing a cushion for debt servicing and shareholder returns.